Asensus Senhance (robot surgeon)

Senhance is a robotic surgeon equipped with three manipulators controlled by a doctor based on high-precision 3D images of the operated area. The system was developed by TransEnterix.

History

2024: Release of robot surgeon version for urological operations for children

On July 23, 2024, Asensus Surgical announced the release of a version of the Senhance robotic surgical system that can be used for urological operations. Specialists will be able to perform such procedures for both adults and children.

The Senhance complex allows surgical interventions to be performed with high accuracy. Moreover, the platform uses the usual minimally invasive methods of laparoscopic surgery in order to improve safety and efficiency without the need for complex training of doctors.

𝓲

Medical Device Network

There may be three or four manipulators around the patient. The equipment includes a camera, the surgeon can control the operation of which using eye movements. The open control cabin provides direct visibility of the sterile field, providing easy access to the patient. There is a wide range of reusable tools with a diameter of 3 mm and 5 mm.

It is claimed that the cost of operating Senhance is comparable to the cost of maintaining traditional laparoscopic equipment. A high level of safety is achieved. Minimally invasive procedures reduce patient rehabilitation time. The intelligent digital system is capable of analyzing the situation, as well as recognizing the actions of the surgeon.

Asensus Surgical has reportedly received approval from the US Food and Drug Administration (FDA) to use the Senhance system in urological operations. The complex can also be used in general laparoscopic and laparoscopic gynecological procedures. Senhance's system combines the benefits of robotics and minimally invasive surgery, it said. The platform's release marks a new step in the development of urological surgery for both adults and children.^[1]

2021: Russian Railways clinic was the first in Russia to purchase a robot surgeon Senhance

On November 29, 2021, Asensus Surgical announced that the first Russian medical institution had acquired the Senhance surgical robotic system. We are talking about the Russian Railways-Medicine clinic in Rostov-on-Don, which has already begun a robotic surgery program using this platform. Read more here.

2020: Entering the Russian market

In December 2020, the Federal Service for Supervision of Health Care (Roszdravnadzor) issued an indefinite registration certificate to the Senhance robot surgeon, developed by the Italian company TransEnterix. An application for registration of a medical product was submitted to the department by MedRegistrar LLC.

Senhance robot surgeon entered the Russian market

According to the registry record in the Roszdravnadzor database, the Senhance robotic surgical system includes, among other things, the following components:

• Arm of the Senhance manipulator;
• Senhance control panel;
• Senhance communication module;
• Control panel monitor;
• Control panel seat;
• Power cable for control panel and manipulator arm (type F);
• Power cable for media module (type F);
• Data transmission cable for manipulator hand;
• Data transmission cable for the control panel;
• Monopolar curved Metzenbaum scissors, long (Ø 3 mm x 280 mm);
• Metzenbaum monopolar curved scissor adapter (Ø 3 mm x 280 mm);
• The dissector is monopolar Maryland, long (Ø 3 mm x 280 mm).

The Senhance model became the second robot surgeon (after Da Vinci from the American Intuitive Surgical), the supply and maintenance of which is carried out by M.P.A. Medical Partners in the Russian Federation. At the same time, the promotion of Senhance in Russia and the CIS is expected to be carried out by BOVA Eurasia (a subsidiary of the German BOWL-electronic).

Among the main advantages of its product, TransEnterix includes the ability to use reusable medical instruments during operations, thanks to which, according to the developers, clinics can save on equipment maintenance.

From the beginning of 2020 to the end of December, six Senhance systems were put into operation around the world, two more installations are being prepared for launch.^[2]

2017:150 operations

In October 2017, it became known that a total of 150 operations were carried out with the help of the Senhance robot surgeon as part of test tests of the system. Its entry into the commercial market is just around the corner, as the novelty has received approval from the American authorities, who also noted that Senhance is not inferior to the more popular da Vinci.

On October 13, 2017, the Food and Drug Administration (FDA) issued a permit to use Senhance to conduct the most complex surgical interventions. 

Senhance robot surgeon

Minimally invasive surgery helps reduce pain, scars and recovery time after surgery, says Binita Ashar, director of surgical devices at the FDA's Radiological Health Center. - The technology used in this robotic surgical assistant is a particular innovation in minimally invasive surgery, designed to visualize and improve access to areas difficult to intervene operationally.

Among the 150 patients operated on with the Senhance robot, there were 45 people who needed serious surgery in the field of colorectal surgery (malfunction of the rectum , anus and colon ). Microscopic cuts of the robot allowed not only to reduce the operation time by almost 30%, but also to practically save patients from scars.

The FDA, having studied the results of these operations and studies, concluded that in gynecological and colorectal operations, the Senhance robot surgeon is as effective and safe as the da Vinci Si IS3000 system.

The researchers believe that the proliferation of robots for minimally invasive surgery can lead to a significant increase in the quality of medical services.^[3]

Notes